Zuddas, Alessandro
University of Cagliari · Azienda Ospedaliera G. Brotzu
21 papers on CoChatORCID 0000-0002-4409-0680
Most cited papers
- Verified
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis
Cortese, S., Adamo, N., Del Giovane, C., Mohr-Jensen, C., Hayes, A. J., Carucci, S., Atkinson, L. Z., Tessari, L., Banaschewski, T., Coghill, D., et al. (2018) · The Lancet Psychiatry
Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices
Cited by 1,402
- Verified
Nonpharmacological Interventions for ADHD: Systematic Review and Meta-Analyses of Randomized Controlled Trials of Dietary and Psychological Treatments
Sonuga-Barke, E. J. S., Brandeis, D., Cortese, S., Daley, D., Ferrin, M., Holtmann, M., Stevenson, J., Danckaerts, M., van der Oord, S., Döpfner, M., et al. (2013) · American Journal of Psychiatry
Attention Deficit Hyperactivity DisorderBehavioral and Psychological Studies
Cited by 1,167
- Verified
European clinical guidelines for hyperkinetic disorder ? first upgrade
Taylor, E., D�pfner, M., Sergeant, J., Asherson, P., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Rothenberger, A., Sonuga-Barke, E., et al. (2004) · European Child & Adolescent Psychiatry
Attention Deficit Hyperactivity DisorderClinical practice guidelines implementation
Cited by 682
- Verified · note
Cognitive Training for Attention-Deficit/Hyperactivity Disorder: Meta-Analysis of Clinical and Neuropsychological Outcomes From Randomized Controlled Trials
Cortese, S., Ferrin, M., Brandeis, D., Buitelaar, J., Daley, D., Dittmann, R. W., Holtmann, M., Santosh, P., Stevenson, J., Stringaris, A., et al. (2015) · Journal of the American Academy of Child & Adolescent Psychiatry
Attention Deficit Hyperactivity DisorderDevelopmental and Educational Neuropsychology
Cited by 627
- Verified
The quality of life of children with attention deficit/hyperactivity disorder: a systematic review
Danckaerts, M., Sonuga-Barke, E. J. S., Banaschewski, T., Buitelaar, J., Döpfner, M., Hollis, C., Santosh, P., Rothenberger, A., Sergeant, J., Steinhausen, H.-C., et al. (2010) · European Child & Adolescent Psychiatry
Attention Deficit Hyperactivity DisorderChild and Adolescent Psychosocial and Emotional Development
Cited by 516
- Verified
Long-acting medications for the hyperkinetic disorders: A systematic review and European treatment guideline
Banaschewski, T., Coghill, D., Santosh, P., Zuddas, A., Asherson, P., Buitelaar, J., Danckaerts, M., Döpfner, M., Faraone, S. V., Rothenberger, A., et al. (2006) · European Child & Adolescent Psychiatry
Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices
Cited by 375
- Verified
European guidelines on managing adverse effects of medication for ADHD
(for the European Guidelines Group), Graham, J., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Dittmann, R. W., Döpfner, M., Hamilton, R., Hollis, C., et al. (2011) · European Child & Adolescent Psychiatry
Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices
Cited by 374
- Verified
ADHD management during the COVID-19 pandemic: guidance from the European ADHD guidelines group
Cortese, S., Asherson, P., Sonuga-Barke, E., Banaschewski, T., Brandeis, D., Buitelaar, J., Coghill, D., Daley, D., Danckaerts, M., Dittmann, R. W., et al. (2020) · The Lancet Child & Adolescent Health
Attention Deficit Hyperactivity DisorderCOVID-19 and Mental Health
Cited by 225
- Verified
The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG)
Coghill, D., Banaschewski, T., Cortese, S., Asherson, P., Brandeis, D., Buitelaar, J., Daley, D., Danckaerts, M., Dittmann, R. W., Doepfner, M., et al. (2023) · European Child & Adolescent Psychiatry
Attention Deficit Hyperactivity DisorderChild and Adolescent Psychosocial and Emotional Development
Cited by 180
- Verified
Association of risk of suicide attempts with methylphenidate treatment
Man, K. K. C., Coghill, D., Chan, E. W., Lau, W. C. Y., Hollis, C., Liddle, E., Banaschewski, T., McCarthy, S., Neubert, A., Sayal, K., et al. (2017) · JAMA Psychiatry
Attention Deficit Hyperactivity DisorderSuicide and Self-Harm Studies
Cited by 140
- Verified
European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder
Coghill, D., Banaschewski, T., Lecendreux, M., Soutullo, C., Johnson, M., Zuddas, A., Anderson, C., Civil, R., Higgins, N., Lyne, A., et al. (2013) · European Neuropsychopharmacology
Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices
Cited by 123
- Verified
Methylphenidate for Pervasive Developmental Disorders: Safety and Efficacy of Acute Single Dose Test and Ongoing Therapy: An Open-Pilot Study
Di Martino, A., Melis, G., Cianchetti, C., & Zuddas, A. (2004) · Journal of Child and Adolescent Psychopharmacology
Attention Deficit Hyperactivity DisorderAutism Spectrum Disorder Research
Cited by 82
- Verified
Systematic Review and Meta-analysis: Screening Tools for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Mulraney, M., Arrondo, G., Musullulu, H., Iturmendi-Sabater, I., Cortese, S., Westwood, S. J., Donno, F., Banaschewski, T., Simonoff, E., Zuddas, A., et al. (2022) · Journal of the American Academy of Child & Adolescent Psychiatry
Attention Deficit Hyperactivity DisorderChild and Adolescent Psychosocial and Emotional Development
Cited by 81
- Verified
Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study
Dell'Agnello, G., Maschietto, D., Bravaccio, C., Calamoneri, F., Masi, G., Curatolo, P., Besana, D., Mancini, F., Rossi, A., Poole, L., et al. (2009) · European Neuropsychopharmacology
Attention Deficit Hyperactivity DisorderChild and Adolescent Psychosocial and Emotional Development
Cited by 54
- Verified
A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABAA-α5 NAM (basmisanil) on intellectual disability associated with Down syndrome
Goeldner, C., Kishnani, P. S., Skotko, B. G., Casero, J. L., Hipp, J. F., Derks, M., Hernandez, M.-C., Khwaja, O., Lennon-Chrimes, S., Noeldeke, J., et al. (2022) · Journal of Neurodevelopmental Disorders
Down syndrome and intellectual disability researchAlzheimer's disease research and treatments
Cited by 48
- Verified
Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe
Coghill, D. R., Banaschewski, T., Nagy, P., Otero, I. H., Soutullo, C., Yan, B., Caballero, B., & Zuddas, A. (2017) · CNS Drugs
Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices
Cited by 45
- Verified
Health-Related Quality of Life and Functional Outcomes from a Randomized-Withdrawal Study of Long-Term Lisdexamfetamine Dimesylate Treatment in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
Banaschewski, T., Johnson, M., Lecendreux, M., Zuddas, A., Adeyi, B., Hodgkins, P., Squires, L. A., & Coghill, D. R. (2014) · CNS Drugs
Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices
Cited by 41
- Verified
A comparison of North American versus non-North American ADHD study populations
Buitelaar, J. K., Barton, J., Danckaerts, M., Friedrichs, E., Gillberg, C., Hazell, P. L., Hellemans, H., Johnson, M., Kalverdijk, L. J., Masi, G., et al. (2006) · European Child & Adolescent Psychiatry
Attention Deficit Hyperactivity DisorderChild and Adolescent Psychosocial and Emotional Development
Cited by 38
- Verified
Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial
Coghill, D. R., Banaschewski, T., Lecendreux, M., Zuddas, A., Dittmann, R. W., Otero, I. H., Civil, R., Bloomfield, R., & Squires, L. A. (2014) · European Child & Adolescent Psychiatry
Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices
Cited by 33
- Verified
Effects of long-term methylphenidate use on growth and blood pressure: results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)
McCarthy, S., Neubert, A., Man, K. K. C., Banaschewski, T., Buitelaar, J., Carucci, S., Coghill, D., Danckaerts, M., Falissard, B., Garas, P., et al. (2018) · BMC Psychiatry
Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices
Cited by 25
- Verified
Predictive validity for the clinical diagnosis of a new parent questionnaire, the CABI, compared with CBCL
Cianchetti, C., Faedda, N., Pasculli, M., Ledda, M. G., Diaz, G., Peschechera, A., Craig, F., Morelli, F., Balottin, U., Guidetti, V., et al. (2020) · Clinical Child Psychology and Psychiatry
Child and Adolescent Psychosocial and Emotional DevelopmentPsychological Testing and Assessment
Cited by 19
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free